Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Open Label Extension of Efgartigimod in Adults with Post-COVID-19 POTS
      Description

      The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19 postural orthostatic.

      Conditions
      Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
      Talk to us
      RECRUITING
      Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS
      Description

      This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID-19\] POTS \[post-COVID-POTS\]).

      Conditions
      Post-COVID Postural Orthostatic Tachycardia Syndrome
      Talk to us
      COMPLETED
      Efficacy and Safety Study of Efgartigimod in Adults with Post-COVID-19 POTS
      Description

      The study aims to investigate the safety, tolerability, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod compared to placebo in participants with post-COVID-19 postural orthostatic tachycardia syndrome (POTS) (post-COVID-19 POTS).

      Conditions
      Postural Orthostatic Tachycardia Syndrome
      Talk to us